Significance of Absent Nasal Bone in Second Trimester Fetus with Normal Nuchal Translucency
An absent nasal bone in a second trimester fetus with normal nuchal translucency indicates an increased risk for trisomy 21 that warrants counseling and offering further aneuploidy evaluation, even with normal NT findings. 1
Risk Assessment and Clinical Significance
Risk of Aneuploidy
- Absent nasal bone is strongly associated with trisomy 21 and other chromosomal abnormalities
- When considered as an isolated marker (with normal NT):
Ethnic Variation
- Important consideration in risk assessment:
Management Algorithm
For Patients with No Previous Aneuploidy Screening:
- Provide counseling about increased risk of trisomy 21 1
- Offer options for evaluation:
- Non-invasive screening via cell-free DNA (cfDNA) testing (preferred)
- Quadruple screen if cfDNA unavailable or cost-prohibitive
- Diagnostic testing via amniocentesis
- Decision depends on clinical circumstances and patient preference
For Patients with Previous Negative Serum Screening:
- Recalculate risk incorporating the absent nasal bone finding
- Discuss options:
- No further evaluation
- Non-invasive screening via cfDNA
- Diagnostic testing via amniocentesis
- The high LR may increase risk above threshold for further evaluation
For Patients with Previous Negative cfDNA Screening:
- No further aneuploidy evaluation recommended 1
- In this context, absent nasal bone is likely a normal variant
Additional Considerations
Comprehensive Anatomic Evaluation
- Careful evaluation of fetal anatomy is warranted as absent nasal bone can be associated with:
Prognostic Implications
- When isolated (no other markers or anomalies) and aneuploidy is excluded:
Common Pitfalls
- Failing to consider ethnic variation - higher prevalence in Afro-Caribbean populations may affect positive predictive value 2
- Not evaluating for additional markers - presence of other markers significantly increases risk 4
- Overreliance on normal NT - absent nasal bone remains significant even with normal NT 1
- Inadequate imaging technique - proper midsagittal plane visualization is essential for accurate assessment 1
Conclusion for Clinical Practice
The finding of an absent nasal bone in the second trimester, even with normal nuchal translucency, represents a significant soft marker for trisomy 21 that should prompt further evaluation. The management approach should be based on previous screening history, with cfDNA testing being the preferred next step for those without prior screening or with previous serum screening. Proper counseling about the increased risk and options for further evaluation is essential.